Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Beutel

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.
Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.
Cancers|August 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLKatrin Teich, Michael Stadler, Razif Gabdoulline, et al.
Frontiers in Pharmacology|May 9, 2015
Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cellsEva M Weissinger, Sylvia Borchers, Anna Silvani, et al.
Oncology Research and Treatment|November 15, 2023
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor OutcomeMaria Madeleine Rüthrich, Yascha Khodamoradi, Julia Lanznaster, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Haematologica|July 18, 2020
Endothelial damage and dysfunction in acute graft-versus-host diseaseSteffen Cordes, Zeinab Mokhtari, Maria Bartosova, et al.
Critical Care Medicine|April 15, 2017
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromePhilipp Wohlfarth, Gernot Beutel, Pia Lebiedz, et al.
Nature Medicine|April 26, 2011
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in miceTibor Kempf, Alexander Zarbock, Christian Widera, et al.
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.
Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.
Cancers|August 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLKatrin Teich, Michael Stadler, Razif Gabdoulline, et al.
Frontiers in Pharmacology|May 9, 2015
Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cellsEva M Weissinger, Sylvia Borchers, Anna Silvani, et al.
Oncology Research and Treatment|November 15, 2023
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor OutcomeMaria Madeleine Rüthrich, Yascha Khodamoradi, Julia Lanznaster, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Haematologica|July 18, 2020
Endothelial damage and dysfunction in acute graft-versus-host diseaseSteffen Cordes, Zeinab Mokhtari, Maria Bartosova, et al.
Critical Care Medicine|April 15, 2017
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromePhilipp Wohlfarth, Gernot Beutel, Pia Lebiedz, et al.
Nature Medicine|April 26, 2011
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in miceTibor Kempf, Alexander Zarbock, Christian Widera, et al.
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Pageof 9